Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

Name: Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL
Published: 2022
License: Public Domain

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

cell-therapy

b-cell non-hodgkin's lymphoma, r/r b-nhl ,cell therapy, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

Related documents